COMPANY PROFILE

Xenome

Explore full profile

Xenome, a biopharmaceutical company, developed a therapeutic product for the management of moderate to severe pain

NorwayFounded 2000Biotechnology

Valuation $25–50M Last recorded · 2011

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Founded: 2000
Headquarters: Norway
Sector: Biotechnology

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

QBQIC BioVentures
GPGBS Venture Partners

Talent

Book a demo to see the people

Employees 4 total headcount

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

🇳🇴 Norway HQ

Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Xenome on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xenome on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles